Abstract
Rituximab and Bendamustine for First-Line Treatment of Frail or Elderly Patients with Aggressive B-Cell Lymphoma: Final Results of the Prospective Phase-II Brenda Trial of GLA (German Lymphoma Alliance)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have